Delta-Sleep-Inducing Peptide and its Derivatives
Biology of Sleep Substances
Delta sleep-inducing nonapeptide
Also indexed as: Delta Sleep Inducing Peptide
A historical book chapter is background literature, not modern independently replicated evidence of insomnia treatment.
Unfamiliar word? Open this panel for simple explanations, right here.
7 glossary terms used in this profile
Select a word to see its meaning. You can keep more than one definition open.
Definitions explain the words—not whether a molecule works or is safe. Research education only, not medical advice.
DSIP stands for delta sleep-inducing peptide, a nine-amino-acid research peptide also called emideltide. Its historical name describes a research hypothesis, not an established effect on human sleep.
Sleep / neuropeptide signaling
Historical experiments explore sleep- and stress-related neuropeptide signaling. A single established receptor mechanism that explains reliable human sleep benefits has not been demonstrated.
A biological pathway describes a proposed or observed interaction—not necessarily a demonstrated health outcome.
Decode the terminology in our glossaryNot enough reliable evidence
There is too little dependable or verified research here to draw a useful conclusion about benefit in people.
For this research: A historical book chapter is background literature, not modern independently replicated evidence of insomnia treatment.
An editorial guide—not a validated score, a percentage, a safety rating or an approval badge. Regulatory status is separate. More research does not mean fewer risks.
Mechanistic laboratory evidence is not separately assessed in this selected-source summary; see references and their study types.
Animal evidence is not separately assessed here. Findings in animals must not be interpreted as demonstrated human benefit.
Associations, biomarker studies and anecdotes cannot establish treatment causality; no observational result is used here to infer clinical effectiveness.
Reliable, independently replicated human outcome evidence is not established by the selected sources in this edition.
No FDA-approved finished drug for this molecule is identified in this edition. Investigational use, published research or compounding does not establish FDA approval.
Historical sleep architecture and stress-response hypotheses.
These describe scientific questions, not prescribing recommendations. A research grouping does not establish combination safety or clinical effectiveness.
Explore research by health goalFDA identifies inadequate safety information and possible immunogenicity and impurity risks. Effects with sedatives and other neuroactive drugs are insufficiently characterized.
This is not an exhaustive safety or contraindication list. An absence of reported harm is not proof of safety. Pregnancy, breastfeeding, cancer history, endocrine disease and concurrent medicines can materially change risk. Unregulated preparations add identity, contamination and sterility risks.
Read FDA’s compounding safety informationNot FDA-approved
No FDA-approved finished drug for this molecule is identified in this edition. Investigational use, published research or compounding does not establish FDA approval.
Regulatory status and evidence strength are different. A nomination for compounding, a clinical-trial registration or a “research use only” label is not approval. International rules vary; consult the current regulator and product label.
Delta-Sleep-Inducing Peptide and its Derivatives
Biology of Sleep Substances
Matched bibliographic records confirm a publication’s identity, not the validity of every claim. Selected sources are not a systematic literature review.
These open search results, not additional verified citations. Trial registration is not evidence that a treatment works.
Beyond the library
Explore our broader health optimization approach. A library entry does not mean a molecule is offered, prescribed, or appropriate for you.
Continue to our existing activation & intake page.
Education, not a prescription. Research summaries are not medical advice, dosing instructions, or an offer to sell. Mechanistic findings do not establish clinical effectiveness. US regulatory status is product- and indication-specific and may change. Discuss health decisions with a licensed clinician.